Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.01 Insider Own1.60% Shs Outstand35.69M Perf Week-0.53%
Market Cap670.97M Forward P/E7.92 EPS next Y2.37 Insider Trans-0.33% Shs Float34.54M Perf Month-23.58%
Income-31.50M PEG- EPS next Q1.34 Inst Own- Short Float22.36% Perf Quarter-21.99%
Sales562.30M P/S1.19 EPS this Y-107.80% Inst Trans-2.39% Short Ratio6.33 Perf Half Y-43.29%
Book/sh26.88 P/B0.70 EPS next Y-53.71% ROA-1.30% Target Price26.50 Perf Year-7.66%
Cash/sh15.65 P/C1.20 EPS next 5Y-12.10% ROE-3.40% 52W Range17.90 - 36.83 Perf YTD-45.98%
Dividend- P/FCF3.36 EPS past 5Y54.30% ROI3.50% 52W High-48.95% Beta1.10
Dividend %- Quick Ratio2.10 Sales past 5Y54.10% Gross Margin77.70% 52W Low5.03% ATR0.96
Employees545 Current Ratio2.20 Sales Q/Q27.60% Oper. Margin5.60% RSI (14)41.34 Volatility5.02% 5.28%
OptionableYes Debt/Eq1.07 EPS Q/Q-390.80% Profit Margin-5.60% Rel Volume1.01 Prev Close18.20
ShortableYes LT Debt/Eq1.04 EarningsMay 02 BMO Payout- Avg Volume1.22M Price18.80
Recom2.70 SMA20-5.12% SMA50-12.91% SMA200-25.93% Volume1,229,442 Change3.30%
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
Nov-19-15Reiterated Deutsche Bank Hold $50 → $43
Sep-03-15Resumed Deutsche Bank Hold $75 → $71
Sep-01-15Initiated Raymond James Outperform $75
Aug-18-15Resumed Jefferies Buy $80
Jun-12-15Initiated Deutsche Bank Hold $75
Jun-09-15Initiated Guggenheim Buy
May-18-15Reiterated Leerink Partners Outperform $60 → $85
Jan-26-15Resumed FBR Capital Mkt Perform $42
Sep-30-14Upgrade FBR Capital Mkt Perform → Outperform $21 → $36
Aug-14-14Initiated FBR Capital Mkt Perform $21
Jan-22-14Downgrade Ladenburg Thalmann Buy → Neutral
Oct-18-13Upgrade Robert W. Baird Neutral → Outperform $25 → $26
Jun-10-13Reiterated Ladenburg Thalmann Buy $25 → $23
May-16-17 08:00AM  AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs GlobeNewswire
May-15-17 09:30AM  Alpha & Omega Semiconductor, AMAG Pharmaceuticals and Trade Desk highlighted as Zacks Bull and Bear of the Day Zacks
08:00AM  AMAG Pharmaceuticals Completes Financing Transactions in Support of Future Growth Strategy GlobeNewswire
07:01AM  Bear of the Day: AMAG Pharmaceuticals (AMAG) Zacks
May-12-17 02:06PM  AMAG Pharmaceuticals, Inc. -- Moody's upgrades AMAG's sr. notes to Ba3; affirms B2 CFR Moody's
May-10-17 08:55AM  What Makes AMAG Pharmaceuticals (AMAG) a Strong Sell? Zacks
08:00AM  AMAG Pharmaceuticals to Host Analyst Day on May 24th in New York GlobeNewswire
May-05-17 03:47PM  ETFs with exposure to AMAG Pharmaceuticals, Inc. : May 5, 2017 Capital Cube
07:00AM  AMAG Pharmaceuticals Announces Pricing of $300 Million of 3.25% Convertible Senior Notes Due 2022 GlobeNewswire
May-04-17 04:01PM  AMAG Pharmaceuticals, Inc. -- Moody's: AMAG's proposed refinancing credit positive Moody's
03:30PM  Edited Transcript of AMAG earnings conference call or presentation 2-May-17 12:00pm GMT Thomson Reuters StreetEvents
10:35AM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube
May-03-17 04:17PM  AMAG Pharmaceuticals Announces Proposed Offering of $250 Million of Convertible Senior Notes due 2022 GlobeNewswire
11:11AM  AMAG Pharma (AMAG) Incurs Loss in Q1, Revenues Rise Y/Y Zacks
May-02-17 09:19AM  Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals TheStreet.com -12.98%
07:55AM  AMAG Pharmaceuticals reports 1Q loss Associated Press
07:01AM  AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
07:00AM  Investor Network: AMAG Pharmaceuticals, Inc. to Host Earnings Call Accesswire
07:00AM  AMAG Announces Positive Topline Data From Phase 3 Feraheme® (ferumoxytol) Label Expansion Study GlobeNewswire
Apr-26-17 08:00AM  AMAG Pharmaceuticals to Present at the Deutsche Bank Health Care Conference GlobeNewswire
Apr-25-17 09:00AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : April 25, 2017 Capital Cube
08:00AM  AMAG Pharmaceuticals Appoints Arpad Simon, M.D. as Vice President of Pharmacovigilance GlobeNewswire
Apr-19-17 08:00AM  AMAG Pharmaceuticals to Host First Quarter 2017 Financial Results Conference Call and Webcast on Tuesday, May 2, 2017 at 8:00 a.m. ET GlobeNewswire
Apr-18-17 10:33AM  AMAG Files for FDA Approval of Subcutaneous Form of Makena Zacks
Apr-17-17 08:00AM  AMAG Submits Supplemental New Drug Application to FDA for Makena® (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use GlobeNewswire
Apr-12-17 01:20PM  AMAG Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMAG) : April 12, 2017 Capital Cube
Apr-11-17 08:16AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : April 11, 2017 Capital Cube
Apr-07-17 08:33AM  15 companies with outsized sales growth and widening profit margins MarketWatch
Apr-05-17 04:43PM  15 companies with outsized sales growth and widening profit margins
Apr-04-17 08:54AM  AMAG Pharmaceuticals stock surges 4% after closing $50 mln licensing agreement for menopause drug MarketWatch
08:00AM  AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement With Endoceutics for U.S. Rights to Intrarosa (Prasterone) GlobeNewswire
Mar-31-17 09:30AM  Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals Zacks
Mar-30-17 10:12AM  5 Toxic Stocks to Get Rid Of or Play Short to Make Gains
10:12AM  5 Toxic Stocks to Get Rid Of or Play Short to Make Gains Investopedia
Mar-28-17 08:00AM  AMAG Pharmaceuticals to Present at the Needham Healthcare Conference GlobeNewswire
Mar-22-17 09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) Motley Fool
Mar-21-17 08:16AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : March 21, 2017 Capital Cube -5.52%
Mar-20-17 07:30AM  Palatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women PR Newswire
Mar-14-17 01:50PM  Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Pharmaceuticals, Inc. (AMAG) Insider Monkey
Mar-06-17 08:29AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Fi
08:00AM  AMAG Announces Management Changes and New Commercial Appointments GlobeNewswire
Mar-01-17 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-27-17 08:00AM  AMAG and Palatin Announce Rekynda Data Presentations at the International Society for the Study of Womens Sexual Health Annual Meeting GlobeNewswire
Feb-24-17 01:04PM  AMAG PHARMACEUTICALS INC. Financials
Feb-21-17 04:41PM  AMAG Pharmaceuticals, Inc. -- Moody's revises outlook on AMAG to stable, affirms B2 CFR at Moody's
06:02AM  AMAG PHARMACEUTICALS INC. Files SEC form 10-K, Annual Report
Feb-16-17 12:54PM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017
11:44AM  AMAG Pharmaceuticals Inks $60M Drug Deal at Investopedia
Feb-15-17 11:01AM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
10:08AM  AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates
Feb-14-17 11:05PM  Edited Transcript of AMAG earnings conference call or presentation 14-Feb-17 1:00pm GMT
09:30AM  Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics
08:00AM  AMAG Pharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:34AM  AMAG Pharmaceuticals reports 4Q loss
07:14AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and F
07:07AM  Q4 2016 AMAG Pharmaceuticals Inc Earnings Release - Before Market Open
07:01AM  AMAG Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:00AM  AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa (Prasterone) GlobeNewswire
Feb-10-17 09:29AM  Agios Pharmaceuticals (AGIO) Q4 Earnings: What's in Store?
09:28AM  Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?
Feb-09-17 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conference GlobeNewswire
Feb-07-17 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on Tuesday, February 14, 2017 at 8:00 a.m. ET GlobeNewswire
Feb-03-17 08:09AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD Discl
08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
08:00AM  AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda (bremelanotide) GlobeNewswire
07:00AM  Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda PR Newswire
Feb-02-17 03:12PM  Here's Why AMAG Pharmaceuticals Is Falling Today at Motley Fool -7.46%
10:40AM  Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results
08:00AM  AMAG Pharmaceuticals Announces Positive Topline Results from Definitive Pharmacokinetic Study for Makena Subcutaneous Administration GlobeNewswire
Jan-19-17 09:35AM  Is AMAG Pharmaceuticals (AMAG) A Good Value Pick?
Jan-11-17 10:22AM  AMAG Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMAG) : January 11, 2017
07:54AM  AMAG Pharma downgraded by Needham
Jan-10-17 04:30PM  Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda PR Newswire
01:18PM  AMAG Pharmaceuticals, Inc. (AMAG), Palatin Technologies, Inc. (PTN) In Licensing Deal at Insider Monkey
08:52AM  AMAG, Palatin Ink Deal to Focus on Female Sexual Disorder
08:37AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : January 10, 2017
Jan-09-17 12:33PM  Why AMAG Pharmaceuticals, Inc. Is Falling Today at Motley Fool -35.57%
08:47AM  New Strong Sell Stocks for January 9th
08:07AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and F
08:01AM  AMAG Pharmaceuticals Provides Financial and Business Update GlobeNewswire
08:00AM  AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekyndatm (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder GlobeNewswire
08:00AM  AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekynda (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder GlobeNewswire
Jan-05-17 02:44PM  Top Biotech Picks: "The Strong Will Survive And Thrive" at Barrons.com
Jan-03-17 08:00AM  AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-23-16 11:07AM  Where Will AMAG Pharmaceuticals Be 1 Year From Now? at Motley Fool
Dec-22-16 04:53PM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
Dec-21-16 08:00AM  AMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors GlobeNewswire
Dec-15-16 08:00AM  AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research GlobeNewswire
Dec-13-16 05:02PM  AMAG Pharma Up On Pre-Eclampsia Drug Potential; Stock On Four-Day Run
Dec-09-16 06:06PM  ICF International Inc (ICFI): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-07-16 06:30AM  Hedge Funds Are Dumping SPX Corporation (SPXC) at Insider Monkey -6.84%
Nov-29-16 01:56PM  Is AMAG Pharmaceuticals, Inc. (AMAG) Going to Burn These Hedge Funds? at Insider Monkey
Nov-07-16 03:11PM  AMAG Pharma (AMAG) Q3 Earnings Up Y/Y, Revenues Beat +7.14%
Nov-04-16 04:10PM  AMAG Pharmaceuticals 3Q Net 43 Cents/Share (AMAG) at Investopedia +5.88%
08:31AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : November 4, 2016
06:03AM  AMAG PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Nov-03-16 04:33PM  Edited Transcript of AMAG earnings conference call or presentation 3-Nov-16 12:00pm GMT -7.93%
10:58AM  AMAG Pharmaceuticals beats Street 3Q forecasts
08:00AM  AMAG Pharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:07AM  Q3 2016 AMAG Pharmaceuticals Inc Earnings Release - Before Market Open
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, manufactures, develops, and commercializes therapeutics for women's health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units for pregnant women and their families. In addition, it has a option agreement with Velo to acquire the rights to digoxin immune fab, a polyclonal antibody in clinical development for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. It has a license agreement with Palatin Technologies, Inc. to research, develop, and commercialize Rekynda, an investigational product designed to be an on-demand treatment for hypoactive sexual desire disorder in pre-menopausal women, as well as with Endoceutics, Inc. to develop and commercialize pharmaceutical products with dehydroepiandrosterone; and development and license agreement with Antares Pharma, Inc. to develop, use, sell, and offer for sale and import and export the Makena auto-injector. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krop JulieSVP Clinical & Regulatory, CMOMay 01Sale24.451,89146,23536,777May 02 05:07 PM
Krop JulieSVP Clinical & Regulatory, CMOOct 20Sale24.804,938122,46223,668Oct 20 04:07 PM